A needle-exchange program in Virginia is a good first step—but isn’t enough by itself.
Sanjay Kishore and Sandeep Kishore
- Scientific American
February 4, 2019
Viewing entries tagged
access to medicines
Modernizing the World Health Organization's official list of vital medications.
Sandeep P. Kishore, Mark D. Huffman, Valentin Fuster, and Rajesh Vedanthan
- Scientific American
April 11, 2018
Given that no official entity is entrusted with making essential medicines on the WHO Essential Medicines List affordable, we suggest that the WHO take a leadership role in addressing this policy gap. Here, we propose a mechanism that could help.
Sandeep Kishore, Rachel Kiddell-Monroe, and Ruth Lopert
- United Nations Secretary-General’s High-Level Panel on Access to Medicines
February 16, 2016
Even in countries like the USA, where the most current cancer treatments are readily available, cost is a serious barrier. In lower-income settings, pricey cancer medications can be impossible to obtain. We discuss the expansion of WHO’s “essential medicines” list to include some high-priced cancer medications and the potential impact it may have on accessibility.
Jordan Jarvis and Sandeep Kishore
- The Lancet United States of Health Blog
May 18, 2015
The recent Executive Board proceedings of the World Health Organization provided new ground for unlikely allies South Africa and Australia, as both struggle to temper intellectual property laws in the interest of public health. We observed the proceedings as non-governmental organization representatives.
Sandeep Kishore and Kavitha Kolappa
- The Huffington Post
February 14, 2014
The march to enhance the access of medicines to treat CVD must now soon match the great strides made for diseases such as HIV/AIDS.
Sandeep Kishore
- Health Affairs
January 13, 2007